Founded in 2002, LabConnect manages a network of global central laboratories with services including routine and esoteric laboratory testing, clinical kit building, sample tracking and management, biorepository and scientific operations support services for biopharmaceutical, medical device and contract research organizations around the world.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 03/02/16 | $4,000,000 |
BroadOak Capital Partners | undisclosed | |
| 06/15/17 | $24,500,000 | Series A |
ABS Capital Partners BroadOak Capital Partners Pablo Capital | undisclosed |
